Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis. | Front Oncol | 2023 | 37152066 | PubTator, text mining | PubMed |
| S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development. | Int J Biol Sci | 2023 | 37151881 | PubTator, text mining | PubMed |
| Hypoxia-elicited Exosomes Promote the Chemoresistance of Pancreatic Cancer Cells by Transferring LncROR via Hippo Signaling. | J Cancer | 2023 | 37151398 | PubTator, text mining | PubMed |
| Oncogenic signaling-mediated regulation of chromatin during tumorigenesis. | Cancer Metastasis Rev | 2023 | 37147457 | PubTator, text mining | PubMed |
| KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. | Nat Commun | 2023 | 37147285 | PubTator, text mining | PubMed |
| Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis. | J Exp Clin Cancer Res | 2023 | 37143164 | PubTator, text mining | PubMed |
| A network map of macrophage-stimulating protein (MSP) signaling. | J Cell Commun Signal | 2023 | 37142846 | PubTator, text mining | PubMed |
| NetBID2 provides comprehensive hidden driver analysis. | Nat Commun | 2023 | 37142594 | PubTator, text mining | PubMed |
| MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target. | Exp Hematol | 2023 | 37137439 | PubTator, text mining | PubMed |
| Mutual connected IL-6, EGFR and LIN28/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy. | Front Oncol | 2023 | 37124491 | PubTator, text mining | PubMed |
| Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target. | Front Immunol | 2023 | 37122725 | PubTator, text mining | PubMed |
| Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression. | Cell Death Differ | 2023 | 37117273 | PubTator, text mining | PubMed |
| Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway. | Chin Med J (Engl) | 2023 | 37114652 | PubTator, text mining | PubMed |
| A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments. | Vaccines (Basel) | 2023 | 37112704 | PubTator, text mining | PubMed |
| An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. | Int J Mol Sci | 2023 | 37108330 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2023 | 37108193 | PubTator, text mining | PubMed |
| From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria. | Biology (Basel) | 2023 | 37106795 | PubTator, text mining | PubMed |
| Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure. | J Cardiovasc Dev Dis | 2023 | 37103015 | PubTator, text mining | PubMed |
| Organ-based clues for diagnosis of inborn errors of immunity: A practical guide for clinicians. | Immun Inflamm Dis | 2023 | 37102642 | PubTator, text mining | PubMed |
| The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy. | Cancer Lett | 2023 | 37094736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=25